Cell Biotech Co Ltd
KOSDAQ:049960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
KR |
|
Pediatrix Medical Group Inc
BMV:MD
|
US |
|
C
|
China Construction Bank Corp
DUS:C6T
|
CN |
|
V
|
Vgi Partners Ltd
ASX:VGI
|
AU |
|
Highgold Mining Inc
XTSX:HIGH
|
CA |
|
Kingfisher PLC
F:KFI2
|
UK |
|
J
|
Jack Chia Industries Thailand PCL
SET:JCT
|
TH |
|
T
|
Thai Mui Corporation PCL
SET:THMUI
|
TH |
|
B
|
BioInvent International AB
STO:BINV
|
SE |
|
C
|
Celestial Acquisition Corp
XTSX:CES.P
|
CA |
|
E
|
ESE Entertainment Inc
OTC:ENTEF
|
CA |
|
AMA Group Ltd
ASX:AMA
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cell Biotech Co Ltd's stock price target?
Not Available
Cell Biotech Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cell Biotech Co Ltd?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is -3%.
What is the Gross Profit forecast for Cell Biotech Co Ltd?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is -2%.
What is the Operating Income forecast for Cell Biotech Co Ltd?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 4 years is -7%.
What is the Pre-Tax Income forecast for Cell Biotech Co Ltd?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 4 years is -8%.
What is the Net Income forecast for Cell Biotech Co Ltd?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is -9%.
